BR9708979A - Complexo imunogénico utilização do mesmo vacina processo para a preparação de um complexo imunogenico e utilização de uma proteína - Google Patents
Complexo imunogénico utilização do mesmo vacina processo para a preparação de um complexo imunogenico e utilização de uma proteínaInfo
- Publication number
- BR9708979A BR9708979A BR9708979A BR9708979A BR9708979A BR 9708979 A BR9708979 A BR 9708979A BR 9708979 A BR9708979 A BR 9708979A BR 9708979 A BR9708979 A BR 9708979A BR 9708979 A BR9708979 A BR 9708979A
- Authority
- BR
- Brazil
- Prior art keywords
- immunogenic complex
- protein
- preparation
- same vaccine
- vaccine process
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9605692A FR2748476B1 (fr) | 1996-05-07 | 1996-05-07 | Complexe immunogene, son utilisation, son procede de preparation et vaccin le contenant |
PCT/FR1997/000800 WO1997041888A1 (fr) | 1996-05-07 | 1997-05-06 | Complexe immunogene, son utilisation, son procede de preparation et vaccin le contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9708979A true BR9708979A (pt) | 1999-08-03 |
Family
ID=9491907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9708979A BR9708979A (pt) | 1996-05-07 | 1997-05-06 | Complexo imunogénico utilização do mesmo vacina processo para a preparação de um complexo imunogenico e utilização de uma proteína |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0914152A1 (de) |
JP (1) | JP2000509707A (de) |
CN (1) | CN1221348A (de) |
AU (1) | AU733845B2 (de) |
BR (1) | BR9708979A (de) |
CA (1) | CA2254084A1 (de) |
FR (1) | FR2748476B1 (de) |
NZ (1) | NZ332809A (de) |
WO (1) | WO1997041888A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2776521B1 (fr) * | 1998-03-27 | 2000-12-15 | Pf Medicament | Utilisation de conjugues p40 actifs par voie nasale |
FR2785542B1 (fr) * | 1998-11-06 | 2001-02-09 | Pf Medicament | UTILISATION D'UNE PROTEINE OmpA D'ENTEROBACTERIE, POUR LE CIBLAGE SPECIFIQUE D'UNE SUBSTANCE BIOLOGIQUEMENT ACTIVE QUI LUI EST ASSOCIEE VERS LES CELLULES PRESENTATRICES D'ANTIGENES TELLES QUE LES CELLULES DENDRITIQUES HUMAINES |
US6146902A (en) * | 1998-12-29 | 2000-11-14 | Aventis Pasteur, Inc. | Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions |
FR2789588B1 (fr) * | 1999-02-17 | 2001-05-04 | Pf Medicament | Utilisation d'une proteine ompa d'enterobacterie associee a un antigene dans une composition pharmaceutique destinee a generer ou accroitre une reponse cytotoxique antivirale, antiparasitaire ou antitumorale |
FR2789902A1 (fr) * | 1999-02-24 | 2000-08-25 | Pf Medicament | PROTEINE OmpA DE KLEBSIELLA PNEUMONIAE ASSOCIEE A LA CHAINE BETA DE L'HORMONE hCG OU A UN COMPOSE IMPLIQUE DANS LA PROLIFERATION DE CELLULES TUMORALES OU DANS LA FERTILITE, UTILE DANS UNE COMPOSITION PHARMACEUTIQUE |
FR2790959B1 (fr) * | 1999-03-15 | 2003-06-27 | Pf Medicament | Utilisation de fractions membranaires bacteriennes a effet adjuvant, leurs procedes de preparation et composition pharmaceutique les contenant |
FR2828106A1 (fr) * | 2001-08-02 | 2003-02-07 | Pf Medicament | Utilisation d'une omp d'enterobacterie de faible masse moleculaire comme porteur et/ou adjuvant |
EP1976857A4 (de) * | 2006-01-13 | 2011-08-03 | Baxter Int | Verfahren zur reinigung von polysacchariden |
CN107184972B (zh) * | 2017-06-20 | 2020-12-01 | 康希诺生物股份公司 | 一种结核杆菌OS-tb寡糖缀合物及其制备方法与应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1331355C (en) * | 1986-04-21 | 1994-08-09 | Bioenterprises Pty. Ltd | Immunopotentation |
FR2682388B1 (fr) * | 1991-10-10 | 1995-06-09 | Pasteur Merieux Serums Vacc | Procede de preparation d'un oligoside par depolymerisation d'un polyoside issu d'un agent pathogene, oligoside ainsi obtenu et son utilisation notamment comme agent vaccinal. |
US6153406A (en) * | 1993-07-23 | 2000-11-28 | North American Vaccine, Inc. | Method for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type B |
FR2718452B1 (fr) * | 1994-04-06 | 1996-06-28 | Pf Medicament | Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation. |
FR2726472B1 (fr) * | 1994-11-07 | 1997-01-31 | Pf Medicament | Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin |
FR2726471B1 (fr) * | 1994-11-07 | 1997-01-31 | Pf Medicament | Procede pour ameliorer l'immunogenicite d'un compose immunogene ou d'un haptene et application a la preparation de vaccins |
-
1996
- 1996-05-07 FR FR9605692A patent/FR2748476B1/fr not_active Expired - Fee Related
-
1997
- 1997-05-06 WO PCT/FR1997/000800 patent/WO1997041888A1/fr not_active Application Discontinuation
- 1997-05-06 CN CN97195397A patent/CN1221348A/zh active Pending
- 1997-05-06 EP EP97923139A patent/EP0914152A1/de not_active Withdrawn
- 1997-05-06 BR BR9708979A patent/BR9708979A/pt not_active Application Discontinuation
- 1997-05-06 CA CA002254084A patent/CA2254084A1/fr not_active Abandoned
- 1997-05-06 AU AU29019/97A patent/AU733845B2/en not_active Ceased
- 1997-05-06 NZ NZ332809A patent/NZ332809A/xx unknown
- 1997-05-06 JP JP9539595A patent/JP2000509707A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
NZ332809A (en) | 2000-05-26 |
AU2901997A (en) | 1997-11-26 |
JP2000509707A (ja) | 2000-08-02 |
FR2748476B1 (fr) | 1998-08-14 |
WO1997041888A1 (fr) | 1997-11-13 |
FR2748476A1 (fr) | 1997-11-14 |
EP0914152A1 (de) | 1999-05-12 |
CN1221348A (zh) | 1999-06-30 |
CA2254084A1 (fr) | 1997-11-13 |
AU733845B2 (en) | 2001-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9710182A (pt) | Embalagem tipo ampola aparelho e processo para fabricar uma embalagem tipo ampola e uso de uma embalagem tipo ampola | |
EE03742B1 (et) | Tramadooli mitmikühikulised preparaadid ja nende valmistamismeetod | |
FI950249A0 (fi) | Sähkökirurgisia kärkiä ja menetelmiä | |
EE9900014A (et) | Erütromütsiinid ja nende valmistamise protsess | |
EE03380B1 (et) | Farmatseutiline aerosoolpreparaat ja selle valmistamismeetod | |
BR9501770A (pt) | Uso de um composto,composto,formulação farmacêutica e processo para preparar um composto | |
EE03778B1 (et) | Vähivaktsiin ja selle valmistamismeetod | |
FI98529B (fi) | Menetelmä ja laitteisto keveiden olefiinien valmistamiseksi | |
BR9502471A (pt) | Composto de guanidina processo para preparar um composto de guanidina composição farmaceutica uso de um composto de guanidina método para o tratamento profilático ou terapêutico de doenças e processo para preparar uma composição farmacêutica | |
DE69502374D1 (de) | Verfahren zur Herstellung von Methylcyanoacrylat | |
EE04681B1 (et) | 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon | |
BR9504463A (pt) | Processo para preparaçao de lipossomas de quetoprofeno e preparaçoes farmacêuticas | |
BR8903705A (pt) | Cabelo artificial para implante capilar e processo e aparelho de preparacao do mesmo | |
BR9600149A (pt) | 2-(2-N-alcoxifenil)-purin-6-onas 9-substituídas processo para sua preparação medicamantos e uso | |
PT949335E (pt) | Processo para preparar dimero purificado de factor derivado de osso | |
AU1631188A (en) | Newcastle disease virus vaccine and method for the application thereof | |
BR9708979A (pt) | Complexo imunogénico utilização do mesmo vacina processo para a preparação de um complexo imunogenico e utilização de uma proteína | |
MX174073B (es) | Procedimiento para la preparacion de sulfatos ciclicos | |
BR9400338A (pt) | Processo para preparação de 1,1,1,2-tetrafluoro-2-cloroetano e de pentafluoretano | |
AU2981395A (en) | Method of identifying and producing antigen peptides and use thereof as vaccines | |
BR9601193A (pt) | Vacina de múltiplos componentes e processos para preparar e administrar a vacina | |
EE9800075A (et) | Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks | |
BR9706239A (pt) | Processo para preparação de 3-(1-hidroxifenil-1-alcoxiimino-metil)dioxazinas | |
BR9600779A (pt) | Benzenossulfoniluréias e -tioréias substituidas processo para sua preparação uso e medicamento | |
BR9400875A (pt) | Formulação para tônico capilar e processo de preparo do mesmo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06A | Notification to applicant to reply to the report for non-patentability or inadequacy of the application according art. 36 industrial patent law | ||
B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |